by H.S. AyoubBioHealth Investor.com In an earlier article, I reviewed Pisano’s book Science Business: the Promise, the Reality, and the Future of Biotech, in which the Harvard business professor provides compelling evidence showcasing the…
Another ‘Fallen Angel’ from Cramer on CNBC’s MAD MONEY is Amgen (AMGN-NASDAQ) after it got crushed last week. He said this is much to do about nothing. The headline risk was that Aranesp was…
The talk of IF Bristol-Myers Squibb (BMY-NYSE) is really going to be gobbled up by Sanofi-Aventis (SNY-NYSE/ADR) hasn’t gone away, but the dust is settling. We covered the ‘media reports’ and what it would…
It would be one of the largest deals in the history of the drug industry. Perhaps the biggest, period. Late reports from Europe are that drug mega company Sanofi-Aventis is in talks to buy…
from BioHealth Investor The upcoming week will be a big one for Hollis Eden Pharmaceuticals (HEPH), a company I’ve written about previously. The company was founded in 1992 and they’ve not advanced a single…
By Vitaliy Katsenelson, CFA January 26, 2007 It seems that 2007 should be a brighter year for Johnson & Johnson (NYSE JNJ). In 2006 the company faced major drug expirations which dampened revenue…
Biotechnology FERMAVIR PHARMACEUTL +19.05% POLYMEDIX INC +14.29% KOSAN BIOSCIENCES +11.11% BIONOVO INC +10.04% NEURO-HITECH INC +9.01% Diagnostic Substances ABAXIS INC +21.00% INFINITY PHARMACEUTI +5.15% GENE LOGIC INC +4.58% PONIARD PHARMA +4.46% IDEXX LABS +3.93%…
The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s Business Daily (1/27/06) scores out of 100 (last week’s rank, change in score): 1(1)…
by H.S. AyoubBioHealth Investor.com After the murder of former Russian intelligence agent Alexander Litvinenko government agencies began to worry about possible future terrorist attacks using the radioactive element polonium-210. Both the National Institute of…
From BioHealth Investor Biotechnology FERMAVIR PHARMACEUTL +17.60% OBAGI MEDICAL +8.72% XTL BIOPHARMACEUTICA +7.31% CYTORI THERAPEUTICS +7.16% MEMORY PHARMACEUTICA +4.64% Diagnostic Substances AVALON PHARMACEUTIC +4.60% ICAGEN, INC. +3.70% PRESSURE BIOSCIENC +2.50% COLEY PHARMACEUTICAL +1.76% ASPENBIO…
From BioHealth Investor by H.S. AyoubBioHealth Investor.com BioLase Technology (BLTI) announced early Thursday that the company had signed a definitive agreement with Proctor & Gamble (PG). Under the terms of the agreement PG will…
Amgen (AMGN-NASDAQ) posted EPS of $0.90, but $0.71 on GAAP EPS. Revenues were $3.73 Billion versus $3.7 Billion estimates. Revenues are projected for $15.4 to $16 Billion for 2007 and adjusted EPS put for…
From BioHealth Investor Biotechnology NEUROBIOLOGICAL TECH +8.26% INTROGEN THERAPEU +7.89% CYTRX CP +7.86% IMMUNE RESPONSE CORP +6.16% EMERGENT BIOSOLUTION +6.12% Diagnostic Substances COLEY PHARMACEUTICAL +10.26% RG GLBL LIFESTYLS +7.58% PALATIN TECH INC +5.26% IMMUNOMEDICS…
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Many would be surprised to learn that obese women are excluded from birth control trials. In today’s society especially, obesity is an ever increasing statistic. It is…
From BioHealth Investor Biotechnology POLYMEDIX INC +16.67% NUTRITION 21 INC +13.76% CYTRX CP +11.17% CORCEPT THERAPEUTICS +8.77% COMPUGEN LTD +8.20% Diagnostic Substances OSTEOLOGIX INC +9.24% AVALON PHARMACEUTIC +7.88% LEXICON GENETICS I +3.73% TORREYPINES THERAPEU…